Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Library of Pharmacologically Active Compounds (LOP

Active
75N98026Q00991Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health, Office of the Director, Office of Acquisitions, is seeking proposals for the Library of Pharmacologically Active Compounds (LOP) under solicitation number 75N98026Q00991, issued as a competitive combined synopsis/solicitation under FAR Subpart 12.6. This procurement is conducted under streamlined procedures for commercial items, utilizing full and open competition without a separate written solicitation, and is not expected to exceed the simplified acquisition threshold. The contract will be awarded on a firm-fixed-price basis to the offeror providing the best value to the government, with proposals due by August 24, 2026. The acquisition is unrestricted and falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, with a small business size standard of 1,300 employees. All provisions and clauses in effect as of the Federal Acquisition Circular dated August 7, 2026, apply to this solicitation. The point of contact for inquiries is Johnstoon, Jaddua C, reachable via email at jaddua.johnston@nih.gov, and the performance location is in Bethesda, Maryland, with the award to be managed by the Department of Health and Human Services.

General Info

NIH seeks firm-fixed-price proposals for LOP library by August 24, 2026, unrestricted, small business eligible, Bethesda, Maryland.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(1)

Sol_75N98026Q00991.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00991. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026

(iv) The associated NAICS code is 325412 Pharmaceutical Preparation Manufacturing and the small business size standard is 1300 employees.

This requirement is unrestricted.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
Non-Addictive Battlefield Pain Management SolutionsThe contract seeks the development of non-opioid analgesics or alternative pain relief technologies designed for military use in austere environments, with a focus on creating effective, non-addictive solutions that can be deployed in combat or field conditions where traditional pain management options are impractical or risky. The work must address the unique challenges of battlefield medicine, including limited resources, extreme climates, and the need for rapid, reliable pain control without the potential for dependency or misuse. The technology must be robust, easily transportable, and compatible with existing military medical protocols and equipment. The contract is structured as a subcontract under the Defense Health Agency, part of the Department of Defense, and is governed by the NAICS code 325412 for pharmaceutical preparation manufacturing. Proposals must be submitted by October 30, 2026, and performance will center in Frederick, with no specific city, state, or zip provided beyond that location. There is no set-aside classification applied to this opportunity, and while no point of contact is listed, interested parties can access additional details through the provided SAM.gov link. The initiative reflects a strategic priority to reduce reliance on opioid-based treatments in military healthcare and advance innovations that enhance soldier readiness and long-term health outcomes.
Defense Health Agency

POSTED

about 20 hours ago

DEADLINE

in 3 months
View Details
NAICS: 325412
New
Federal
Government Contracting Compliance & GSA Schedule SupportThe contract solicits the supply of biotechnology reagents through existing GSA Schedule or GWAC vehicles, requiring full compliance with the Federal Acquisition Regulation for pricing and delivery terms. All offerings must leverage pre-negotiated, FAR-compliant contractual mechanisms to ensure transparency, affordability, and efficiency in procurement by the National Institutes of Health, specifically the National Institute on Drug Abuse under the Department of Health and Human Services. The NAICS code 325412 confirms the primary focus on pharmaceutical and biological product manufacturing, indicating the need for high-purity, research-grade reagents suitable for scientific and clinical applications. Responses must be submitted by August 13, 2026, and the contract is structured as a subcontract, implying the awardee will fulfill obligations under a prime contract holder rather than directly with the government. Performance is expected to align with federal supply chain standards, though no specific place of performance or set-aside criteria are provided. Compliance with GSA Schedule or GWAC terms is mandatory, ensuring that pricing remains consistent with established federal rates and that delivery timelines meet agency operational needs. The solicitation underscores the importance of proven regulatory adherence and reliable supply chain execution to support critical biomedical research activities.
National Institutes Of Health Nida

POSTED

2 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
Federal
Specialty Biotech Reagent Manufacturing (dCODE Dextramer®)The contract involves the manufacture of specialized immunology reagents based on dextramer technology, specifically customizable HLA-peptide complexes equipped with fluorescent barcoding, intended for use in research and clinical applications. These reagents are designed to enable precise detection and analysis of antigen-specific T cells, supporting advancements in immunological studies and potential therapeutic development. The production must meet stringent quality and consistency standards to ensure reliability across diverse experimental and diagnostic settings, with an emphasis on scalability and customization to accommodate varying peptide and HLA combinations. This is a subcontract under the National Institutes of Health, specifically the National Institute on Drug Abuse, part of the Department of Health and Human Services, with the NAICS code 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, and responses are due by August 13, 2026, with no set-aside classification specified. The place of performance and other location details are not provided, indicating flexibility in where the manufacturing may occur, though all work must comply with the technical and regulatory requirements for clinical-grade reagents. The focus is squarely on advanced biotech manufacturing capabilities, emphasizing precision, reproducibility, and compliance with industry best practices for immune monitoring tools.
National Institutes Of Health Nida

POSTED

2 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
Federal
Virus-Vectored Oral Rabies Vaccine Bait – Fishmeal Polymer FormulationThe contract pertains to the supply of fishmeal polymer-based vaccine baits with part number 128425, specifically formulated as a virus-vectored oral rabies vaccine intended for targeted wildlife species. These baits are designed to deliver rabies immunization in a palatable, durable form that supports effective distribution in野外 environments, leveraging a fishmeal polymer matrix to ensure stability and attraction for target animals. The work under this subcontract is tied to efforts led by the USDA’s APHIS-Wildlife Services division to manage and reduce the spread of rabies among wildlife populations through strategic oral vaccination campaigns. The solicitation was posted on August 6, 2026, with submissions due by September 7, 2026, at 9:00 PM. The North American Industry Classification System code 325412 indicates the work falls under pharmaceutical and biological product manufacturing, underscoring the scientific and regulatory rigor expected in production. Performance is required to occur in Concord, New Hampshire, with a ZIP code of 03301, though no specific office address or point of contact is provided. The nature of the contract as a subcontract suggests it supports a broader federal wildlife health initiative, likely underpinning national or regional rabies control programs managed by the Department of Agriculture.
Aphis-Ws

POSTED

2 days ago

DEADLINE

in about 1 month
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541715
New
Federal
Rat PK for the DYT1 lead compound
Solicitation # 75N98026Q00987
The National Institutes of Health, Office of the Director, Office of Acquisitions, is soliciting proposals under solicitation number 75N98026Q00987 for research and development services related to rat pharmacokinetics for the DYT1 lead compound. This is a competitive combined synopsis and solicitation issued under FAR Subpart 12.6 for commercial items, utilizing full and open competition without a separate written solicitation. The contract will be awarded on a firm-fixed-price basis to the offeror providing the best value to the government, with no set-aside designated and the requirement remaining unrestricted. The North American Industry Classification System code is 541715, with a small business size standard of 1,000 employees, and the solicitation is conducted under the streamlined procedures authorized by FAR 12.603, not expected to exceed the simplified acquisition threshold. Proposals must be submitted by the deadline of August 24, 2026, and all terms and conditions are governed by the Federal Acquisition Circular effective August 7, 2026. The work is to be performed in support of the NIH in Bethesda, Maryland, with primary point of contact being John Johnston, reachable via email at jaddua.johnston@nih.gov. This acquisition is not tied to any specific location beyond the agency’s office in Bethesda and is intended to procure commercial services in the field of physical, engineering, and life sciences research, excluding nanotechnology and biotechnology. All interested parties must respond through the provided SAM.gov link and adhere to the submission requirements outlined in the solicitation document.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 20 hours ago

DEADLINE

in 16 days
View Details
NAICS: 541715
New
Federal
Maximum Tolerated Dose (MTD) Evaluation of PIP4Kga
Solicitation # 75N98026Q00989
The National Institutes of Health, Office of the Director, Office of Acquisitions, is soliciting proposals under solicitation number 75N98026Q00989 for the Maximum Tolerated Dose (MTD) Evaluation of PIP4Kga, utilizing a commercial items acquisition process under FAR Subpart 12.6. This combined synopsis/solicitation is issued as a competitive, full and open opportunity using a firm-fixed-price contract structure, with no set-aside designated, and is not expected to exceed the simplified acquisition threshold. The requirement falls under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences, with a small business size standard of 1,000 employees, and is unrestricted to all eligible offerors. Proposals must be submitted by the deadline of August 24, 2026, and the solicitation incorporates all applicable provisions and clauses in effect as of August 7, 2026. The NIH seeks the best value proposal from responsible vendors capable of delivering the required research and development services, which will involve evaluating the MTD of PIP4Kga through scientifically rigorous methodologies. The place of performance and specific technical requirements are not detailed in the public notice, but inquiries should be directed to the primary point of contact, Johnstons Johnston, at jaddua.johnston@nih.gov. The acquisition is being conducted under the streamlined procedures of FAR 12.603, eliminating the need for a separate written solicitation, and all responses must be submitted through the designated SAM.gov portal. The contract award will be made based on factors demonstrating overall value, including technical capability, past performance, and price competitiveness.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 20 hours ago

DEADLINE

in 16 days
View Details